Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
Replay – IPO Edge Going-Public Boot Camp with Nasdaq, Gallagher, Vinson & Elkins, Stifel, ICR, GTS, Morrow Sodali
The recent market turmoil has put much of the IPO market in limbo. But...
Join IPO Edge’s Going-Public Boot Camp Mar. 29 with Nasdaq, Gallagher, Vinson & Elkins, Stifel, ICR, GTS, Morrow Sodali
The recent market turmoil has put much of the IPO market in limbo. But...
Gesher I Acquisition Corp. Gets Additional Capital Before Target Announced
By Jarrett Banks Tel Aviv-based Gesher I Acquisition Corp. (Nasdaq: GIAC), a SPAC, entered...
Local Bounti Cracks the Code on Profitable Indoor Farming
– Local Bounti (NYSE: LOCL) is an “agtech” operator focusing sustainable production, delivery of...
On Holding Updates 2022 Guidance Following Record Sales, Demand
By Alan Hatfield On Holding AG (NYSE: ONON) updated its 2022 guidance, reporting record...
Video Highlights – Cannabis Meets Blockchain: Join Exotix Founder in Fireside Chat
IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with...
Duckhorn Portfolio Sees Double-Digit Growth on Demand for Luxury Wines
By Alan Hatfield St. Helena, CA-based winemaker The Duckhorn Portfolio, Inc. (NYSE: NAPA) yesterday...
